| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/29/2009 | CA2335663C Cosmetic and pharmaceutical oil-in-water emulsions |
| 12/29/2009 | CA2299548C Composition and method for regulating cell proliferation and cell death |
| 12/29/2009 | CA2291087C Compositions suitable for controlled release of the hormone gnrh and its analogs |
| 12/29/2009 | CA2247522C Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090319016 Process for production of porous body and uses thereof |
| 12/24/2009 | US20090318570 Skin protection compositions, in particular cream to protect against cold |
| 12/24/2009 | US20090318569 Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby |
| 12/24/2009 | US20090318568 Adherent coating for tissue surface and/or trans-tissue surface substance delivery |
| 12/24/2009 | US20090318519 Process for release of biologically active species |
| 12/24/2009 | US20090318398 Androgen pharmaceutical composition and method for treating depression |
| 12/24/2009 | US20090317485 Skin Protectant Spray Compositions |
| 12/24/2009 | US20090317480 Chimeric immunomodulatory compounds and methods of using the same-ii |
| 12/24/2009 | US20090317453 Transdermal and topical administration of drugs using basic permeation enhancers |
| 12/24/2009 | US20090317451 Pressure-sensitive adhesive for skin surface and/or transdermal substance delivery |
| 12/24/2009 | US20090317437 Cellulose gel formulations |
| 12/24/2009 | US20090317412 Induction of an immune response against streptococcus pneumoniae polyaccharides |
| 12/24/2009 | US20090317379 Autophilic antibodies and method of making the same |
| 12/24/2009 | US20090317343 Personal Care Compositions Containing Silicone Elastomer Gels |
| 12/24/2009 | US20090317342 Use of flavonoids |
| 12/24/2009 | US20090317327 Aqueous Dispersion of Superparamagnetic Single-Domain Particles, Production and Use Thereof in Diagnosis and Therapy |
| 12/23/2009 | WO2009155397A2 Edible holographic silk products |
| 12/23/2009 | WO2009155335A2 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization |
| 12/23/2009 | WO2009154978A2 Self-preserved emulsions |
| 12/23/2009 | WO2009154447A1 Heat-stable, aqueous lactoferrin composition and its preparation and use |
| 12/23/2009 | WO2009154396A2 Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
| 12/23/2009 | WO2009154304A2 A pharmaceutical composition |
| 12/23/2009 | WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 12/23/2009 | WO2009154086A1 Water-soluble acrylic acid salt polymer and gelling base |
| 12/23/2009 | WO2009153888A1 Drug carrier |
| 12/23/2009 | WO2009153704A1 Concentrated oxaliplatin solution and its method of preparation |
| 12/23/2009 | WO2009153448A1 Oral composition containing an anti-plaque agent of the thienopyridine family in the form of a base |
| 12/23/2009 | WO2009153447A1 Oral galenic form, polymer production method and use of same |
| 12/23/2009 | WO2009153209A1 Modified polymeric pro-fragrance |
| 12/23/2009 | WO2009153200A1 Preparation containing glucosamine and/or chondroitin for prophylaxis and treatment of arthrosis and for supporting the immune system |
| 12/23/2009 | WO2009153019A1 Composition for transdermal delivery of cationic active agents |
| 12/23/2009 | WO2009152691A1 A polyglycol modified chitosan oligosaccharide fatty acid graft, preparation method thereof and use of the same |
| 12/23/2009 | WO2009152610A1 Interleukin-2/soluble tgf-beta type ii receptor b conjugates and methods and uses thereof |
| 12/23/2009 | WO2009152597A2 Topical use composition for combatting ectoparasites in dogs and cats |
| 12/23/2009 | WO2009133137A3 Pegylated recombinant human growth hormone compounds |
| 12/23/2009 | WO2009132048A3 Treating eosinophilic esophagitis |
| 12/23/2009 | WO2009129511A3 Fluocinolone formulations in a biodegradable polymer carrier |
| 12/23/2009 | WO2009121069A3 Compositions and methods for the preparation of nanoemulsions |
| 12/23/2009 | WO2009110009A3 Opthalmic composition |
| 12/23/2009 | WO2009095639A3 Freezable lubricant |
| 12/23/2009 | WO2009095562A3 Biomaterial for the controlled delivery of ingredients |
| 12/23/2009 | WO2009068996A3 Conjugated beta-1,3-linked glucans |
| 12/23/2009 | WO2009053596A3 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 12/23/2009 | WO2009036092A3 Mitochondria-targeted anti-tumour agents |
| 12/23/2009 | WO2008155487A3 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x |
| 12/23/2009 | WO2008089257A3 Drug eluting medical device using polymeric therapeutics with transglutaminase substrates |
| 12/23/2009 | EP2135605A2 Therapeutic delivery of carbon monoxide |
| 12/23/2009 | EP2135600A1 Targeting agent for cancer cell or cancer-associated fibroblast |
| 12/23/2009 | EP2135512A1 Compound based on malic acid, caffeic acid, a flavan-3-ol and an anthocyane and its use in food and medicine |
| 12/23/2009 | EP2134740A2 Self-assembling nanoparticle drug delivery system |
| 12/23/2009 | EP2134353A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
| 12/23/2009 | EP2134337A1 Novel burn treatment composition |
| 12/23/2009 | EP2134334A1 Nanoparticulated anesthetic composition for topic use |
| 12/23/2009 | EP2134329A1 Composition and microsphere for controlled-release of exendin, and method of preparing the same |
| 12/23/2009 | EP2134321A2 Orally administrable films |
| 12/23/2009 | EP2134320A1 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 12/23/2009 | EP1613302B1 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
| 12/23/2009 | EP1450822B1 Polyalkylene oxide conjugates of thiol-containing drugs |
| 12/23/2009 | EP1420787B1 Ophthalmic composition comprising an ascomycin |
| 12/23/2009 | EP1356816B1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 12/23/2009 | EP1274861B1 Compositions and methods for identifying and targeting cancer cells |
| 12/23/2009 | EP1107782B1 Oral vaccine compositions |
| 12/23/2009 | CN201366104Y Externally-applied gynecological suppository with active protein and nano-silver |
| 12/23/2009 | CN101610792A Method for coupling keratin-binding polypeptides with effector molecules which support carboxylic groups or sulfonic acid groups |
| 12/23/2009 | CN101610791A Composition for promoting bone regeneration and restoration |
| 12/23/2009 | CN101610784A PTH formulations and methods of use |
| 12/23/2009 | CN101610778A Broad-spectrum antiviral composition having excellent storage stability |
| 12/23/2009 | CN101610759A Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 12/23/2009 | CN101610756A Method for stabilising blood plasma components in a lyophilisate |
| 12/23/2009 | CN101610754A Pharmaceutical composition containing fine particle oil-based suspension |
| 12/23/2009 | CN101608006A Preparation method of double-network hydrogel |
| 12/23/2009 | CN101607983A Encephalitis B virus PrM/M protein B cell antigen epitope polypeptide and applications |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN101607091A Method for synthesizing dextran-magnetic LDH-fluorouracil magnetic targeting sustained and controlled release tripolymer |
| 12/23/2009 | CN101607090A Sulphur butyl ether-beta-schardinger dextrin inclusion compound of cephalosporin sulbactam ester |
| 12/23/2009 | CN101607089A External wrapping membrane and external wrapping membrane soft capsule thereof |
| 12/23/2009 | CN101607088A Method for synthesizing magnetic layered composite hydroxide |
| 12/23/2009 | CN101607080A Oral drug for treating diabetes and preparation method thereof |
| 12/23/2009 | CN101607078A Traditional Chinese medicine five-feng amino acid nutritional plaster matrix and preparation of externally applied plaster of matrix |
| 12/23/2009 | CN101607068A Traditional Chinese medicine pro-liposome injection for treating liver cancer and preparation process thereof |
| 12/23/2009 | CN101607014A Ointment for promoting tissue regeneration and restraining sore and preparation method thereof |
| 12/23/2009 | CN101606989A Novel preparation method of trollius chinensis granular preparation |
| 12/23/2009 | CN101606985A Liniment for treating sheep infective pustule virus and preparation method thereof |
| 12/23/2009 | CN101606964A Veterinary traditional Chinese medical compound preparation |
| 12/23/2009 | CN101606962A Sugarless south isatis root granules and preparation method thereof |
| 12/23/2009 | CN101606959A Acupoint implanted drug for treating psoriasis |
| 12/23/2009 | CN101606939A Fat-soluble vitamin freeze-dried powder needle and preparation method thereof |
| 12/23/2009 | CN101606935A Solid medicinal composition containing clopidogrel |
| 12/23/2009 | CN101606934A Bendamustine hydrochloride compound |
| 12/23/2009 | CN101606931A Erdosteine composition and preparation method thereof |
| 12/23/2009 | CN101606926A Medicinal composition containing dopexamine hydrochloride |
| 12/23/2009 | CN101606925A 贴剂和贴剂制剂 Patch and patch preparation |
| 12/23/2009 | CN101606923A Stable controlled-release rasagiline transdermal patch and preparation method thereof |
| 12/23/2009 | CN101606921A Acarbose solid sustained-release preparation and preparing method thereof |
| 12/23/2009 | CN101606917A Sustained-release tablet of salt of huperzine A with one-time administration for everyday |